Biohit Oyj (HEL:BIOBV)
Finland
· Delayed Price · Currency is EUR 3.540
-0.040 (-1.12%)
At close: Dec 5, 2025
Biohit Oyj Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 14.28 | 14.28 | 13.08 | 10.95 | 9.36 | 7.12 | Upgrade
|
| Revenue Growth (YoY) | 2.20% | 9.23% | 19.41% | 16.98% | 31.42% | -29.14% | Upgrade
|
| Cost of Revenue | 4.64 | 4.94 | 4.61 | 3.84 | 3.45 | 3.17 | Upgrade
|
| Gross Profit | 9.64 | 9.34 | 8.46 | 7.11 | 5.92 | 3.96 | Upgrade
|
| Selling, General & Admin | 4.1 | 4 | 4.09 | 3.63 | 3.45 | 3.06 | Upgrade
|
| Other Operating Expenses | 2.74 | 2.44 | 2.19 | 1.87 | 1.98 | 2.07 | Upgrade
|
| Operating Expenses | 7.18 | 6.78 | 6.64 | 5.98 | 7.42 | 7.13 | Upgrade
|
| Operating Income | 2.46 | 2.56 | 1.83 | 1.13 | -1.5 | -3.17 | Upgrade
|
| Interest Expense | -0.3 | - | - | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | 0.03 | -0.01 | 0.02 | -0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.56 | 0.56 | 0.41 | -0.29 | 0.09 | -0.16 | Upgrade
|
| EBT Excluding Unusual Items | 2.82 | 3.12 | 2.26 | 0.83 | -1.39 | -3.34 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.25 | -0.25 | -0.07 | 0.04 | 0.06 | 0.08 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | 0.02 | - | Upgrade
|
| Pretax Income | 2.57 | 2.87 | 2.2 | 0.87 | -1.31 | -3.26 | Upgrade
|
| Income Tax Expense | 0.3 | 0.3 | 0.34 | 0.27 | 0.2 | 0.05 | Upgrade
|
| Earnings From Continuing Operations | 2.27 | 2.57 | 1.85 | 0.6 | -1.5 | -3.31 | Upgrade
|
| Net Income | 2.27 | 2.57 | 1.85 | 0.6 | -1.5 | -3.31 | Upgrade
|
| Net Income to Common | 2.27 | 2.57 | 1.85 | 0.6 | -1.5 | -3.31 | Upgrade
|
| Net Income Growth | 37.37% | 38.74% | 207.99% | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 15 | 15 | 15 | 15 | 15 | 15 | Upgrade
|
| Shares Outstanding (Diluted) | 15 | 15 | 15 | 15 | 15 | 15 | Upgrade
|
| Shares Change (YoY) | 0.50% | 0.58% | 0.41% | 0.13% | - | 0.27% | Upgrade
|
| EPS (Basic) | 0.15 | 0.17 | 0.12 | 0.04 | -0.10 | -0.22 | Upgrade
|
| EPS (Diluted) | 0.15 | 0.17 | 0.12 | 0.04 | -0.10 | -0.22 | Upgrade
|
| EPS Growth | 36.91% | 41.15% | 200.41% | - | - | - | Upgrade
|
| Free Cash Flow | 0.38 | 0.18 | 0.65 | 1.79 | -0.48 | -0.04 | Upgrade
|
| Free Cash Flow Per Share | 0.03 | 0.01 | 0.04 | 0.12 | -0.03 | -0.00 | Upgrade
|
| Gross Margin | 67.49% | 65.39% | 64.73% | 64.94% | 63.19% | 55.57% | Upgrade
|
| Operating Margin | 17.20% | 17.90% | 13.96% | 10.30% | -16.02% | -44.56% | Upgrade
|
| Profit Margin | 15.88% | 17.98% | 14.16% | 5.49% | -16.02% | -46.51% | Upgrade
|
| Free Cash Flow Margin | 2.69% | 1.29% | 5.00% | 16.34% | -5.10% | -0.56% | Upgrade
|
| EBITDA | 2.52 | 2.62 | 1.93 | 1.34 | 0.23 | -1.39 | Upgrade
|
| EBITDA Margin | 17.64% | 18.34% | 14.78% | 12.24% | 2.46% | -19.51% | Upgrade
|
| D&A For EBITDA | 0.06 | 0.06 | 0.11 | 0.21 | 1.73 | 1.78 | Upgrade
|
| EBIT | 2.46 | 2.56 | 1.83 | 1.13 | -1.5 | -3.17 | Upgrade
|
| EBIT Margin | 17.20% | 17.90% | 13.96% | 10.30% | -16.02% | -44.56% | Upgrade
|
| Effective Tax Rate | 11.65% | 10.43% | 15.67% | 30.76% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.